Seminars in Radiation Oncology
Volume 16, Issue 1 , Pages 51-58, January 2006

Radiation and New Molecular Agents Part I: Targeting ATM-ATR Checkpoints, DNA Repair, and the Proteasome

  • Ananya Choudhury, MA, MRCP (FRCR)
  • ,
  • Andrew Cuddihy, PhD
  • ,
  • Robert G. Bristow, MD, PhD (FRCPC)

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Robert G. Bristow, MD, PhD, FRCPC, Department of Radiation Oncology, Princess Margaret Hospital, Room 5-923 610 University Avenue Toronto, Ontario, Canada.

Departments of Radiation Oncology and Medical Biophysics, University of Toronto and Princess Margaret Hospital-University Health Network, Toronto, Ontario, Canada

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by operating grants from the Terry Fox Foundation, National Cancer Institute of Canada, Ontario Cancer Research Network, the Prostate Cancer Research Foundation of Canada, and the US Army DOD Prostate Cancer Research Program. RGB is a Canadian Cancer Society Research Scientist. The first two authors contributed equally to this manuscript.

PII: S1053-4296(05)00051-2

doi:10.1016/j.semradonc.2005.08.007

Seminars in Radiation Oncology
Volume 16, Issue 1 , Pages 51-58, January 2006